INOVIO PHARMACEUTICALS, INC. Property, Plant and Equipment
INOVIO PHARMACEUTICALS, INC. (INO) had Property, Plant and Equipment of $1.89 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-12
- 2026-06-30: Property, Plant and Equipment, Net $1.89M.
- 2026-03-31: Property, Plant and Equipment, Net $2.21M.
- 2025-12-31: Property, Plant and Equipment, Net $2.53M.
- 2025-09-30: Property, Plant and Equipment, Net $2.74M.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $1.89M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $2.21M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $2.53M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $2.74M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.09M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $3.35M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $3.66M 10-K · filed 2026-03-12 |
| 2024-09-30 | $4.09M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $4.51M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $5.02M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $4.96M 10-K · filed 2025-03-18 |
| 2023-09-30 | $5.63M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $6.30M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $6.98M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $7.73M 10-K · filed 2024-03-06 |
| 2022-09-30 | $15.59M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $16.21M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $16.70M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $17.45M 10-K · filed 2023-03-01 |
| 2021-09-30 | $17.58M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $18.11M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $10.93M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $11.35M 10-K · filed 2022-03-01 |
| 2020-09-30 | $11.19M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $11.32M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $12.10M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $12.77M 10-K · filed 2021-03-01 |
| 2019-09-30 | $13.52M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $14.27M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $15.19M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $15.95M 10-K · filed 2020-03-12 |
| 2018-09-30 | $16.23M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $16.87M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $17.49M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $18.32M 10-K · filed 2019-03-12 |
| 2017-09-30 | $18.47M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $15.02M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $9.80M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $9.03M 10-K · filed 2018-03-14 |
| 2016-09-30 | $8.99M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $8.70M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $8.39M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $7.31M 10-K · filed 2017-03-15 |
| 2015-09-30 | $6.46M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $5.50M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $4.95M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $4.58M 10-K · filed 2016-03-14 |
| 2014-09-30 | $4.63M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $4.55M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $3.02M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $2.89M 10-K · filed 2015-03-16 |
| 2013-09-30 | $2.29M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $348.12K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $362.89K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $363.02K 10-K · filed 2014-03-17 |
| 2012-09-30 | $391.53K 10-Q · filed 2012-11-07 |
| 2012-06-30 | $421.52K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $355.30K 10-Q · filed 2012-05-09 |
| 2011-12-31 | $295.79K 10-K · filed 2013-03-18 |
| 2011-09-30 | $288.85K 10-Q · filed 2011-11-07 |
| 2011-06-30 | $306.11K 10-Q · filed 2011-08-05 |
| 2010-12-31 | $276.80K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |